New York Investor Charles R. Broderick studied at both MIT and Harvard and now plans on giving back to both in the field of cannabis research reports Harvard News. Totaling $9 million, they represent the largest cannabinoid science research donations to date. The funds are allocated to support expert research in the fields of neuroscience and biomedicine with the aim of unraveling the biology of cannabinoids, studying their effects on the human brain, catalyze treatments and inform evidence-based clinical guidelines, societal policies and regulation of cannabis.
Mr. Broderick is quoted- “our desire is to fill the research void that currently exists in the science of cannabis.” Known as Bob, Broderick founded Uji Capital LLC, a family office focused on quantitative opportunities in global equity and capital markets. Trained in computer sciences, Broderick moved through a variety of interesting positions including quantitative-focused positions in investment banking. He has been a significant investor in the emerging cannabis economy—especially in Canada.
The gits will be channeled to Harvard Medical School (HMS) and MIT’s School of Science (through the Picower Institute for Learning and Memory and the McGovern Institute for Brain Research.) $4.5 million will be awarded to the Charles R Broderick Phytocannabinoid Research Initiative at HMS funding basic translational and clinical research across the school community with the hopes of generating core insights about the effects of cannabinoids. Core research leadership at HMS will include neurobiologists Bruce Bean and Wade Regehr.